Company intelligence / Profile preview

Valdospan

Madrid, Madrid, Spain
Ownership
Private
Development stage
Other
01

Overview

Valdospan is a pharmaceutical entity based in Spain that operates as a subsidiary of the Servier Group. The company is primarily associated with the commercialization and distribution of agomelatine (marketed under brand names such as Valdoxan and Thymanax) within the Spanish market. Agomelatine is a melatonergic antidepressant used for the treatment of major depressive episodes in adults, functioning as a melatonin receptor agonist and a selective serotonin receptor antagonist. Valdospan supports Servier's broader mission in the central nervous system therapeutic area by managing local regulatory and commercial operations for these psychiatric treatments.

Therapeutic areas
Psychiatry
Modalities
Small molecule
Industry
Pharma
02

Drug pipeline

2 assets

HPV E7 degrader

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Valdospan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valdospan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call